| Announce Date | 05/09/2023 |
| EPS Normalized Actual | $0.11 In Line |
| EPS GAAP Actual | $0.11 In Line |
| Revenue Actual | $0.00829236B |
| Revenue Surprise | Beat by $8.29236M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $-0.18 |
| EPS GAAP Estimate | $-0.18 |
| Revenue Estimate | $0.008614B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2030 | -0.23 | -17 | -0.23 | -0.23 | 1 |
| Dec 2029 | -0.03 | -130.33 | -0.03 | -0.03 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -0.13 | 0 | 0.00829236B | -9.57% | -1.35M |
| FQ2 2025 (Jun 2025) | -0.0495 | -0.0495 | 0.0108374B | 9.12% | 0M |
| FQ1 2025 (Mar 2025) | 0.08 | 0.08 | 0.0117131B | 27.45% | 11.71M |
| FQ4 2024 (Dec 2024) | -0.14 | -1.68141 | 0.0104356B | 10.37% | 1.77M |
| FQ3 2024 (Sep 2024) | -0.11 | -1.45259 | 0.00908583B | -11.01% | 0.51M |
| FQ2 2024 (Jun 2024) | -0.0769 | -1.41949 | 0.00984885B | -10.56% | -7.8M |
| FQ1 2024 (Mar 2024) | -0.14 | -1.71645 | 0.0084977B | -8.55% | -4.51M |
| FQ4 2023 (Dec 2023) | -0.44 | -0.01 | 0.00935307B | 100% | -15.08M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
-0.18
Consensus Revenue Estimates
0.008614B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ3 2027 (Sep 2027) | -0.01 | -- | -0.01 | -0.01 | 1 |
| FQ2 2027 (Jun 2027) | -0.01 | -- | -0.01 | -0.01 | 1 |
| FQ1 2027 (Mar 2027) | -0.11 | -- | -0.11 | -0.11 | 1 |
| FQ4 2026 (Dec 2026) | -0.13 | -- | -0.13 | -0.13 | 1 |
| FQ3 2026 (Sep 2026) | -0.13 | 0 | -0.13 | -0.13 | 1 |
| FQ2 2026 (Jun 2026) | -0.06 | 17.5 | -0.06 | -0.06 | 1 |
| FQ1 2026 (Mar 2026) | -0.18 | 144.44 | -0.18 | -0.18 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ3 2027 (Sep 2027) | 0.01B | -- | 0.01B | 0.01B | 14 |
| FQ2 2027 (Jun 2027) | 0.01B | -- | 0.01B | 0.01B | 9 |
| FQ1 2027 (Mar 2027) | 0.01B | -- | 0.01B | 0.01B | 9 |
| FQ4 2026 (Dec 2026) | 0.01B | -- | 0.01B | 0.01B | 16 |
| FQ3 2026 (Sep 2026) | 0.01B | 2.48 | 0.01B | 0.01B | 9 |
| FQ2 2026 (Jun 2026) | 0.01B | -10.79 | 0.01B | 0.01B | 10 |
| FQ1 2026 (Mar 2026) | 0.01B | -35.98 | 0.01B | 0.01B | 16 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
1
EPS # of Misses
6
EPS # of in-lines
1
Revenue # of Beats
4
Revenue # of Misses
4
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -0.13 | -0.13 | 0 | 0% |
| FQ2 2025 (Jun 2025) | 0 | -0.0495 | -0.0495 | 100% |
| FQ1 2025 (Mar 2025) | 0.08 | 0.08 | 100% | |
| FQ4 2024 (Dec 2024) | 1.54141 | -0.14 | -1.68141 | 1201.01% |
| FQ3 2024 (Sep 2024) | 1.34259 | -0.11 | -1.45259 | 1320.54% |
| FQ2 2024 (Jun 2024) | 1.34259 | -0.0769 | -1.41949 | 1845.89% |
| FQ1 2024 (Mar 2024) | 1.57645 | -0.14 | -1.71645 | 1226.04% |
| FQ4 2023 (Dec 2023) | -0.43 | -0.44 | -0.01 | 2.27% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0.01B | $0.01B | $-1.35M | -16.24% |
| FQ2 2025 (Jun 2025) | $0.01B | $0.01B | $0M | 0% |
| FQ1 2025 (Mar 2025) | $0B | $0.01B | $11.71M | 100% |
| FQ4 2024 (Dec 2024) | $0.01B | $0.01B | $1.77M | 16.97% |
| FQ3 2024 (Sep 2024) | $0.01B | $0.01B | $0.51M | 5.56% |
| FQ2 2024 (Jun 2024) | $0.02B | $0.01B | $-7.8M | -79.21% |
| FQ1 2024 (Mar 2024) | $0.01B | $0.01B | $-4.51M | -53.11% |
| FQ4 2023 (Dec 2023) | $0.02B | $0.01B | $-15.08M | -161.23% |